DmAMP1, an antifungal plant defensin from Dahlia merckii, was shown previously to require the presence of sphingolipids for fungicidal action against Saccharomyces cerevisiae. Sphingolipids may stabilize glycosylphosphatidylinositol (GPI)-anchored proteins, which interact with DmAMP1, or they may directly serve as DmAMP1 binding sites. In the present study, we demonstrate that S. cerevisiae disruptants in GPI-anchored proteins showed small or no increased resistance towards DmAMP1 indicating no involvement of these proteins in DmAMP1 action. Further, studies using an enzyme-linked immunosorbent assay (ELISA)-based binding assay revealed that DmAMP1 interacts directly with sphingolipids isolated from S. cerevisiae and that this interaction is enhanced in the presence of equimolar concentrations of ergosterol. Therefore, DmAMP1 antifungal action involving membrane interaction with sphingolipids and ergosterol is proposed.
Introduction
Plant defensins are small (45^54 amino acid residues), highly basic, cysteine-rich peptides that possess antifungal and/or antibacterial activity at micromolar concentrations (reviewed in [1, 2] ). They are active against a broad range of phytopathogenic fungi and human pathogens (such as Candida albicans) [3] . Plant defensins appear not to be toxic to either mammalian or plant cells. Experimental evidence points towards a role of the plant defensins in defending the host plant from fungal attack (reviewed in [1, 4] ). Up to date, more than 80 di¡erent defensins have been identi¢ed in 38 di¡erent plant species belonging to various plant families [1] . The global fold of plant defensins comprises a cysteine-stabilized KL motif (CSKL motif) consisting of an K-helix and a triple-stranded L-sheet, organized in a LKLL architecture and stabilized by four disul¢de bridges. Regarding amino acid composition, the plant defensin family is quite diverse ; sequence conservation is restricted to eight structurally important cysteines.
DmAMP1, a plant defensin isolated from seeds of dahlia (Dahlia merckii), induces an array of relatively rapid responses in fungal membranes, including increased K þ e¥ux, increased Ca 2þ uptake, increased uptake of £uores-cent dyes, and membrane potential changes [5, 6] . Furthermore, the existence of high-a⁄nity binding sites for DmAMP1 on fungal cells and plasma membrane fractions was demonstrated [7] . Via a genetic complementation approach, IPT1 was identi¢ed as a gene determining sensitivity towards DmAMP1 in Saccharomyces cerevisiae [8] . IPT1 encodes an enzyme involved in the last step of the synthesis of the sphingolipid mannosyldiinositolphosphorylceramide (M(IP) 2 C) [9] . M(IP) 2 C, mannosylinositolphosphorylceramide (MIPC) and inositolphosphorylceramide (IPC) are the three major classes of sphingolipids in S. cerevisiae. S. cerevisiae strains with a non-functional IPT1 allele lacked M(IP) 2 C in their membranes, bound signi¢cantly less DmAMP1 compared to parental S. cerevisiae strain, and were highly resistant to DmAMP1-induced membrane permeabilization [8] . Recently, we have shown that DmAMP1 sensitivity is not linked with the presence of a functional IPT1-encoding protein (Ipt1p) but with the presence of M(IP) 2 C in the fungal plasma membrane [8, 10] . Possibly, membrane patches containing sphingolipids act as binding sites for DmAMP1, or alternatively, are required to anchor membrane or cell wallassociated proteins that interact with DmAMP1. Subsequently, this interaction could lead to insertion of DmAMP1 into the membrane resulting in membrane destabilization.
Sphingolipids associate with sterols in the plasma membrane to form patches (also referred to as rafts) that are highly enriched in glycosylphosphatidylinositol (GPI)-anchored membrane proteins [11] . In this study, we investigated whether such GPI-anchored proteins are involved in constituting the binding site for DmAMP1 or whether DmAMP1 interacts directly with the S. cerevisiae sphingolipids. Finally, we investigated a possible e¡ect of ergosterol, the main fungal sterol, on the interaction between DmAMP1 and yeast sphingolipids.
Materials and methods

Materials and microorganisms
DmAMP1 was isolated as described previously [12] . Anti-DmAMP1 serum from rabbit was purchased from Eurogentec (Seraing, Belgium). Phosphatase-coupled goat anti-rabbit immunoglobulins, bovine serum albumin (BSA) and ergosterol were purchased from Sigma (St. Louis, MO, USA). Yeast strains used in this study were S. cerevisiae parental strain BY4741 (Invitrogen, Carlsbad, CA, USA) and S. cerevisiae BY4741 disruption mutants (Euroscarf, Frankfurt, Germany) in the following genes encoding non-essential GPI-anchored proteins:
S. cerevisiae parental strain SEY6210 and corresponding double and triple yeast disruption mutants vccw12vccw13 and vccw12vccw13vccw14 were kindly provided by Prof.
Widmar Tanner (Universita «t Regensburg, Regensburg, Germany).
Antifungal activity assay
Antifungal activity of DmAMP1 against yeast strains was assayed by microscopic analysis of liquid cultures grown in microtiter plates as described previously [7] .
2.3. Isolation of S. cerevisiae sphingolipids S. cerevisiae sphingolipids were prepared from commercial freeze-dried yeast (Saf-instant, SAFMEX S.A. DE C.V., Mexico) using the procedures of Smith and Lester [13] . After hydration (24 g dry weight of cells per 100 ml water), treatment with 5% trichloroacetic acid (15 min, room temperature), washing the precipitate (by centrifugation with 0.5% KH 2 PO 4 ), and heating (95 ‡C, 7 min), the lipids were extracted with 95% ethanol:diethylether:pyridine (15:5:1 vol per vol) and deacylated (glacial acetic acid, pH 5.5). A mixture of sphingolipids composed of IPC, MIPC, and M(IP) 2 C was puri¢ed from the extract of non-deacylated lipids using the alternative method of Smith and Lester [13] by methanol precipitation for several days followed by Chelex 100 (Sigma Chem. Co, St. Louis, MO, USA) chromatography. Purity and composition were analyzed by silica gel thin-layer chromatography as described by Im et al. [10] , and typical preparations showed approximately equal proportions of IPC, MIPC, and M(IP) 2 C as judged by orcinol-H 2 SO 4 staining of thinlayer chromatographic plates [13] .
Construction of S. cerevisiae double deletion mutants in GPI-anchored proteins
Gene disruption of CWP2 and YHR126 in both vcwp1 and vykl046c S. cerevisiae deletion mutants was accomplished by replacing the coding region of CWP2 and YHR126 with the URA auxotrophic marker gene as described by Brachmann et al. [27] , resulting in four double deletion mutants, namely vcwp1vcwp2, vykl046cvcwp2, vcwp1vyhr126c and vykl046cvyhr126c. Correct gene transplacement was veri¢ed by polymerase chain reaction (PCR).
Microtiter plate binding assay (enzyme-linked immunosorbent assay (ELISA))
Interaction of DmAMP1 with sphingolipids was evaluated by using an ELISA-based assay as described previously [3,14^16] . Stock solutions of sphingolipids and ergosterol were prepared in methanol:chloroform :water (16:16:5; vol:vol:vol) at a concentration of 1 mM. Lipids were applied in 75-Wl aliquots to the wells of microtiter plates and allowed to dry overnight at room temperature. All subsequent handling steps were performed at 37 ‡C. 
Results
Involvement of GPI-anchored proteins in constituting the DmAMP1 interaction site
In a ¢rst instance, we investigated the possibility that a member of the group of so-called GPI-anchored proteins might constitute the DmAMP1 binding site, or at least might be involved in DmAMP1 activity. Use of the Von Heijne algorithm and homology searches allowed the identi¢cation of 58 open reading frames (ORFs) in the genome of S. cerevisiae that encode proteins with a putative GPI attachment signal in their signal sequences [26] . S. cerevisiae disruptants in the 54 non-essential plasma membrane and cell wall GPI-anchored proteins were tested for increased resistance towards DmAMP1. S. cerevisiae disruptants in GPI-anchored cell wall proteins (GPI-CWPs) vyhr126c and vykl046c showed a 2-fold increase in DmAMP1 resistance (data not shown). Besides vyhr126c and vykl046c, none of these yeast deletion mutants showed an increased level of resistance against DmAMP1 as compared to S. cerevisiae parental strain BY4741 (data not shown). It therefore seems unlikely that a speci¢c GPIanchored protein acts as a docking site for DmAMP1, facilitating its insertion into the plasma membrane. However, a remaining possibility is that DmAMP1 interacts with a common constituent, present on several GPI-anchored proteins. To test this hypothesis, various double deletion mutants in non-essential GPI-CWPs were constructed. Since (i) CWP1 and CWP2 are the most abundant GPI-CWPs in S. cerevisiae [17] and (ii) based on the above-mentioned results on a putative involvement of YHR126c and YKL046c in DmAMP1 sensitivity, four S. cerevisiae double deletion mutants were generated, namely vcwp1vcwp2, vykl046cvcwp2, vcwp1vyhr126c and vykl046cvyhr126c, and tested for increased DmAMP1 resistance. In addition, DmAMP1 resistance of a double (vccw12vccw13) and triple (vccw12vccw13vccw14) S. cerevisiae deletion mutant in mannosylated GPI-CWPs [18] was assessed (Table 1) . However, none of these S. cerevisiae deletion mutants showed more than 2-fold increased DmAMP1 resistance as compared to the corresponding S. cerevisiae parental strains. These data indicate that none of the tested GPI-anchored proteins plays a principal role in the fungal growth inhibiting process by DmAMP1.
Interaction of DmAMP1 with sphingolipids isolated from S. cerevisiae
To get more insight in the involvement of fungal sphingolipids in DmAMP1-mediated growth inhibition, the interaction between DmAMP1 and sphingolipids isolated from S. cerevisiae was assessed. To this end, we developed an ELISA-based binding assay in which sphingolipids are coated to the wells of microtiter plates and interacting peptides are detected immunologically [3,14^16] . Using the ELISA-based binding assay, DmAMP1 was found to interact in a dose-dependent manner with puri¢ed sphingolipids from S. cerevisiae. Saturability of the interaction of DmAMP1 with 15 pmol of coated sphingolipids occurred at a DmAMP1 concentration of 1 WM (which corresponds to 75 pmol DmAMP1 per well, a 5-fold molar DmAMP1 excess) (Fig. 1A) . The interaction of 1 WM DmAMP1 with di¡erent amounts of coated sphingolipids is presented in Fig. 1B . Optimal interaction of 1 WM DmAMP1 with fungal sphingolipids was observed at 15 pmol of sphingolipids coated per well.
Since sphingolipids are associated with sterols in the plasma membrane to form patches, we further investigated the e¡ect of ergosterol, the main fungal sterol, on the interaction of DmAMP1 with fungal sphingolipids. In a ¢rst instance, interaction of 1 WM DmAMP1 with di¡erent concentrations of ergosterol (ranging from 1 pmol to 1 nmol coated per well) was assessed. In these conditions, no interaction of DmAMP1 with ergosterol could be observed (data not shown). Furthermore, interaction of 1 WM DmAMP1 with lipid mixtures consisting of 15 pmol sphingolipids and di¡erent amounts of ergosterol was assessed. As can be seen in Fig. 2 , addition of ergosterol at concentrations ranging from 7.5 to 150 pmol (corresponding to 25 to 90 mol% ergosterol) increased the interaction of DmAMP1 with sphingolipids with 30^50%, with a maximal e¡ect at equimolar concentrations of sphingolipids and ergosterol.
Discussion
Our studies show that DmAMP1 interacts in a dosedependent manner with sphingolipids isolated from the plasma membrane of S. cerevisiae and that this interaction is enhanced in the presence of equimolar concentrations of ergosterol, the main fungal sterol. These ¢ndings point towards a direct role of sphingolipids in the fungal growth inhibiting process by DmAMP1. Sphingolipids are, together with sterols and phospholipids, one of the three major classes of eukaryotic membrane components. The composition of the plasma membrane of fungal cells is asymmetric, which is typical of eukaryotic cells, with phosphatidylserine mainly in the inner lea£et, and sterols and sphingolipids in the outer lea£et [19] . The ergosterol to sphingolipid ratio of the yeast plasma membrane can be estimated at 1.4 [19] . We have demonstrated optimal DmAMP1 interaction with an equimolar mixture of ergosterol and yeast sphingolipids, re£ecting the in vivo yeast plasma membrane composition. It has been shown that sphingolipids and sterols are enriched in speci¢c domains in the outer plasma membrane, the so-called membrane rafts [11, 20] . Possibly, DmAMP1 interacts with fungal sphingolipids, which are concentrated in such speci¢c rafts. Interaction of DmAMP1 with these rafts could result in high local concentrations of these membrane-bound defensins. Whether a threshold concentration of membrane-bound DmAMP1 is a prerequisite for membrane disruption, as hypothesized for the structurally related human L-defensins [21] , remains unclear. After interaction with the rafts, DmAMP1 is supposed to insert into the plasma membrane, resulting in membrane permeabilization. Whether fungal growth arrest is a direct consequence of increased membrane permeability or results from interaction of DmAMP1 with an intracellular target is currently under investigation.
Similarly to DmAMP1, a plant defensin from radish (RsAFP2) has been shown to directly interact with fungal glucosylceramides [3] . Besides sphingolipids, such as IPC, MIPC and M(IP) 2 C, glucosylceramides are another class of sphingolipids that are present in membranes of most fungi, except in S. cerevisiae. There is growing evidence that fungi maintain two separate pools of ceramides to be used for the synthesis of di¡erent sphingolipids [22] . Ceramide backbones with very long chain C 24 and C 26 fatty acids bound to the sphingobase 4-hydroxysphinganine are directed to the synthesis of the inositolphosphoryl-containing sphingolipids, whereas ceramide backbones with C 16 or C 18 fatty acids linked to the sphingobase 9-methyl-4,8-sphingadienine are exclusively used as precursors for biosynthesis of glucosylceramide. As such, RsAFP2 and DmAMP1 represent two groups of plant defensins with regard to target speci¢city on the fungal membrane.
Interestingly, it has recently been shown that sphingolipids are important pathogenicity determinants. A Cryptococcus neoformans mutant with lowered levels of sphingolipids showed reduced pathogenicity in a rabbit model [23] . The ¢nding that DmAMP1 is active against the human pathogen C. albicans [3, 24] and that it may target potential pathogenicity factors present in most fungi, opens interesting perspectives for the development of novel antimycotics [24] .
